StockTipsArenaBeta

BUY Vimta Labs Limited — Sandeep Jain, Tradeswift

BUYVimta Labs Limited

bySandeep Jain, TradeswiftHorizon: NA (inferred Swing (≤2wk))27 Jul 2026via Zee Business (Live)

Entry₹581.15Inferred
Target₹660
Total upside +13.57% (call closed)
Stop loss₹550-5.36% risk
Exit₹6605 Aug 2026, 9:20 am
Target hit+13.57%0.00%upside left
Follow Sandeep Jain for new calls(21% target hit, 43 closed calls)Get alertsWatch VIMTALABS for new buy/sell callsGet alertsSee 2 active Swing calls on VIMTALABS

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 5 Aug 2026
8 supporting2 neutral1 opposing
Supports the BUY call (8)

1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · same horizon·5 Aug · today

Laurus Labs: Q1FY26-27 Profit More Than Doubles as CDMO Business Hits Record High

NewsGoogle News·30 Jul · 5d ago

(opens in new tab)

Vimta Labs Q1 FY27 Income Up 13.7% To ₹112.9 Crore, Biologics Facility Operational

NewsGoogle News·24 Jul · 2w ago

(opens in new tab)

Vimta Labs: पहिल्या तिमाहीत दमदार वाढ, ₹112.9 कोटींचा महसूल, नवीन Biologics सुविधा सुरू

NewsGoogle News·24 Jul · 2w ago

(opens in new tab)

Vimta Labs Q1FY27 PAT rises 11.4% to ₹210.42 Mn

NewsGoogle News·21 Jul · 2w ago

(opens in new tab)
Neutral / worth noting (2)

Vimta Labs Limited announced its unaudited financial results for the first quarter ended June 30, 2026. The results were reviewed by the Audit Committee and approved by the Board of Directors.

BSE · Board Meeting·20 Jul · 2w ago

(opens in new tab)

Vimta Labs Limited has submitted its unaudited financial results for the quarter ended June 30, 2026, along with a limited review report, as approved by the Board of Directors.

NSE · Outcome of Board Meeting·20 Jul · 2w ago

(opens in new tab)
Weighs against the BUY call (1)

Earnings call transcript: Vimta Labs Q1 2026 shares fall 5.4% after solid growth

NewsGoogle News·20 Jul · 2w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.